Detalhe da pesquisa
1.
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
N Engl J Med
; 384(2): 105-116, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33185990
2.
Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study.
J Card Fail
; 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215932
3.
The HFSA Advanced Heart Failure and Transplant Cardiology Fellowship Consensus Conference.
J Card Fail
; 30(2): 391-398, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806488
4.
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.
J Card Fail
; 30(1): 26-35, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683911
5.
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.
Eur Heart J
; 44(1): 41-50, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36254693
6.
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial.
Circulation
; 146(4): 279-288, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377706
7.
Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure.
Circ Res
; 128(10): 1468-1486, 2021 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33983837
8.
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.
Eur Heart J
; 43(48): 5006-5016, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675469
9.
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
Eur Heart J
; 43(23): 2212-2220, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325102
10.
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.
Circulation
; 144(16): 1284-1294, 2021 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34459213
11.
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
Circulation
; 143(4): 326-336, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33081531
12.
Effects of Serelaxin in Patients with Acute Heart Failure.
N Engl J Med
; 381(8): 716-726, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433919
13.
Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial.
JAMA
; 328(3): 259-269, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852527
14.
Challenges and Potential Improvements to Patient Access to Pharmaceuticals: Examples From Cardiology.
Circulation
; 142(8): 790-798, 2020 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833519
15.
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials.
Am Heart J
; 240: 73-80, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34107289
16.
The Additive Prognostic Value of Serial Plasma Interleukin-6 Levels over Changes in Brain Natriuretic Peptide in Patients with Acute Heart Failure.
J Card Fail
; 27(7): 808-811, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33497808
17.
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure.
J Card Fail
; 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33663906
18.
Drug development in oncology and devices-lessons for heart failure drug development and approval? a review.
Heart Fail Rev
; 26(2): 255-262, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32939666
19.
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Eur Heart J
; 41(22): 2109-2117, 2020 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32498081
20.
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.
Circulation
; 140(25): 2108-2118, 2019 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31841369